Tardive Dyskinesia
Conditions
Keywords
tardive dyskinesia
Brief summary
The statistical analysis of the collected data aims to reveal the many factors that influence patient involvement in clinical trials. Findings will be disseminated through conferences and scholarly papers to benefit all parties participating in clinical trials. These findings will help to shape the design of future clinical trials for people with tardive dyskinesia, as well as enhance recruiting techniques and retention rates.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of tardive dyskinesia * Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed * No prior treatment for tardive dyskinesia
Exclusion criteria
* Enrolled in another research study * Inability to provide written informed consent * Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of patients who decide to enroll in a tardive dyskinesia clinical research. | 3 months |
| Number of tardive dyskinesia study participants who remain in clinical study until completion. | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed